ArticlePharmaceuticals (Basel, Switzerland)2022

Introduction of a SiFA Moiety into the D-Glutamate Chain of DOTA-PP-F11N Results in Radiohybrid-Based CCK-2R-Targeted Compounds with Improved Pharmacokinetics In Vivo.

Nadine Holzleitner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.